Tag: ai in in vitro diagnostics market growth

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The integration of artificial intelligence into in vitro diagnostics is transforming the healthcare landscape with rapid advancements and growing demand. As technology continues to evolve, this market is set to experience significant expansion, driven by innovations that enhance diagnostic accuracy and personalized patient care. Let’s explore the current market size, key growth factors, emerging trends, top players, and regional insights shaping this dynamic sector.

Steady Growth and Market Size Projections for AI in In Vitro Diagnostics

The artificial intelligence in in vitro diagnostics market has seen impressive growth in recent years. It is projected to rise from $3.04 billion in 2025 to $3.6 billion in 2026, marking a compound annual growth rate (CAGR) of 18.4%. This growth during the historical period has been fueled by heightened demand for precise diagnostic tools, expanding laboratory infrastructure, the increasing burden of chronic diseases, the adoption of digital diagnostic technologies, and progress in biomarker research.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

Looking further ahead, the market is expected to surge to $7.01 billion by 2030, with a compound annual growth rate of 18.1%. Key factors driving this expansion include the growth of cloud-based diagnostic platforms, deeper integration of AI with genomics, the development of point-of-care AI diagnostics, rising investments in personalized medicine, and the growing need for faster and more affordable testing solutions. Among the trends shaping the future of this market are AI-powered laboratory automation, predictive diagnostics for diseases, data-driven interpretation of tests, cloud-based platforms, and personalized patient profiling.

Personalized Medicine as a Catalyst for AI in In Vitro Diagnostics Growth

One of the foremost factors propelling the AI in in vitro diagnostics market is the increasing emphasis on personalized medicine. This healthcare approach customizes prevention, diagnosis, and treatment based on an individual’s genetic makeup, lifestyle, and environment. Advances in genomic sequencing and data analytics are enabling more precise and targeted therapies tailored to individual patients, which in turn demand sophisticated diagnostic tools powered by AI.

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Global Footprint: Which Region Holds Market Leadership?

Artificial intelligence plays a crucial role by analyzing complex diagnostic data to uncover patient-specific disease patterns, enabling timely and accurate treatment decisions. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, a significant rise from six approvals in 2022. These new treatments include seven cancer drugs and three for other conditions, highlighting the growing reliance on personalized approaches that are driving demand for AI-enhanced diagnostics.

Segment Breakdown Highlighting Rapidly Expanding Categories in the AI in In Vitro Diagnostics Market

This market is segmented by component, technology, deployment model, application, and end user to provide a comprehensive view of its scope. Components include software, hardware, and services, while technologies involve machine learning, natural language processing, computer vision, robotic process automation, and deep learning. Deployment models range from cloud-based and on-premise to hybrid solutions.

Applications cover diagnostic imaging, laboratory testing, pathology, genomics, and personalized medicine. End users consist of hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical companies, and medical device manufacturers. Further subcategories include software types such as diagnostic algorithms, data analytics platforms, and decision support systems; hardware like laboratory instruments, imaging devices, and point-of-care devices; and services including consulting, implementation, maintenance, support, training, and education.

Innovative Industry Trends Enhancing Market Growth for AI in In Vitro Diagnostics

Leading companies in this space are focusing on creating advanced AI solutions that improve diagnostic accuracy and streamline clinical workflows. A notable development is the emergence of CE-IVDR-certified transparent AI platforms, which comply with EU regulations while offering clear and auditable decision-making processes to build clinical trust and ensure compliance.

For instance, in May 2025, Diagnostics.ai, a UK-based company, introduced PCR.AI, a smart tool designed to accelerate and improve the accuracy of PCR diagnostics. This platform automates real-time interpretation with over 99.9% accuracy and provides transparency on how results are generated, enhancing laboratory efficiency and regulatory adherence in molecular diagnostics.

Top Companies Driving Innovation and Competition in the AI in In Vitro Diagnostics Market

Several key players dominate the artificial intelligence in in vitro diagnostics market, including Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, and Aiforia Technologies Oyj. These companies are leading efforts to advance AI technologies and expand their application across diagnostic fields.

Regional Market Leadership and Growth Prospects in AI for In Vitro Diagnostics

In 2025, North America held the largest share of the artificial intelligence in in vitro diagnostics market, reflecting strong adoption and infrastructure. Meanwhile, the Asia-Pacific region is anticipated to be the fastest-growing market over the forecast period, driven by expanding healthcare systems and increasing investments. Other regions analyzed include South East Asia, Western and Eastern Europe, South America, the Middle East, and Africa, providing a global perspective on market trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market During The 2026–2030 Period?

The market for artificial intelligence (AI) in in vitro diagnostics (IVD) has experienced substantial growth recently. This market is projected to expand from $3.04 billion in 2025 to reach $3.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.4%. Factors contributing to its historical expansion include a heightened need for precise diagnostic methods, the development of laboratory infrastructure, the growing incidence of chronic ailments, the integration of digital diagnostic instruments, and breakthroughs in biomarker research.

The market for artificial intelligence (ai) in in vitro diagnostics (ivd) is projected to experience substantial expansion over the coming years. This market is anticipated to reach $7.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. This anticipated growth is driven by factors such as the proliferation of cloud-based diagnostic platforms, the incorporation of AI with genomics, advancements in point-of-care AI diagnostics, increased funding in personalized medicine, and a rising need for swift and economical testing solutions. Key trends expected during this period involve AI-powered laboratory automation, diagnostic tools for predicting diseases, interpretation of tests based on data, continued adoption of cloud-based diagnostic platforms, and individualized patient profiling.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

What Market Drivers Are Helping Shape The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Expansion?

The increasing demand for personalized medicine is expected to drive the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market in the future. Personalized medicine defines a healthcare method that customizes prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. The rise of personalized medicine is fueled by progress in genomic data and sequencing technologies, which enable more accurate, targeted, and effective treatments tailored to individual patients. Artificial intelligence (AI) in in vitro diagnostics (IVD) assists personalized medicine by analyzing complex diagnostic data to identify patient-specific disease patterns, thereby enabling precise, timely, and tailored treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also included seven cancer drugs and three for other diseases and conditions. Therefore, the growing demand for personalized medicine is powering the growth of the artificial intelligence (AI) in in vitro diagnostics (IVD) market.

What Are The Major Segment Categories Within The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning

3) By Deployment Model: Cloud-Based, On-Premise, Hybrid

4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:

1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems

2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices

3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

What Trends Are Influencing The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Outlook?

Leading companies within the artificial intelligence (AI) in in vitro diagnostics (IVD) market are prioritizing the creation of advanced solutions, including CE-IVDR-certified transparent AI platforms, with the goal of improving diagnostic precision, streamlining operational processes, and supporting individualized patient treatment. A CE-IVDR-certified transparent AI platform refers to an AI system for in vitro diagnostics that adheres to EU regulatory standards and delivers clear, auditable, and easily understandable decision-making. As an illustration, in May 2025, Diagnostics.ai, a diagnostic testing firm based in the UK, unveiled PCR.AI, an intelligent solution aimed at expediting and enhancing PCR diagnostics. This system automates and accelerates the interpretation of real-time PCR diagnostics with an accuracy exceeding 99.9%. It ensures transparency by explicitly detailing how each result is reached, thus securing regulatory compliance and elevating clinical confidence. This development markedly boosts laboratory efficiency, reduces inaccuracies, and facilitates uninterrupted regulatory adherence for molecular diagnostics.

Which Companies Form The Competitive Landscape Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj

Access The Complete Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

Which Region Contributes The Most To The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company

Artificial Intelligence In The Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Ai In Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Ai In Medical Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market During The 2026–2030 Period?

The market for artificial intelligence (AI) in in vitro diagnostics (IVD) has experienced substantial growth recently. This market is projected to expand from $3.04 billion in 2025 to reach $3.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.4%. Factors contributing to its historical expansion include a heightened need for precise diagnostic methods, the development of laboratory infrastructure, the growing incidence of chronic ailments, the integration of digital diagnostic instruments, and breakthroughs in biomarker research.

The market for artificial intelligence (ai) in in vitro diagnostics (ivd) is projected to experience substantial expansion over the coming years. This market is anticipated to reach $7.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. This anticipated growth is driven by factors such as the proliferation of cloud-based diagnostic platforms, the incorporation of AI with genomics, advancements in point-of-care AI diagnostics, increased funding in personalized medicine, and a rising need for swift and economical testing solutions. Key trends expected during this period involve AI-powered laboratory automation, diagnostic tools for predicting diseases, interpretation of tests based on data, continued adoption of cloud-based diagnostic platforms, and individualized patient profiling.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

What Market Drivers Are Helping Shape The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Expansion?

The increasing demand for personalized medicine is expected to drive the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market in the future. Personalized medicine defines a healthcare method that customizes prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. The rise of personalized medicine is fueled by progress in genomic data and sequencing technologies, which enable more accurate, targeted, and effective treatments tailored to individual patients. Artificial intelligence (AI) in in vitro diagnostics (IVD) assists personalized medicine by analyzing complex diagnostic data to identify patient-specific disease patterns, thereby enabling precise, timely, and tailored treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also included seven cancer drugs and three for other diseases and conditions. Therefore, the growing demand for personalized medicine is powering the growth of the artificial intelligence (AI) in in vitro diagnostics (IVD) market.

What Are The Major Segment Categories Within The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning

3) By Deployment Model: Cloud-Based, On-Premise, Hybrid

4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:

1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems

2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices

3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

What Trends Are Influencing The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Outlook?

Leading companies within the artificial intelligence (AI) in in vitro diagnostics (IVD) market are prioritizing the creation of advanced solutions, including CE-IVDR-certified transparent AI platforms, with the goal of improving diagnostic precision, streamlining operational processes, and supporting individualized patient treatment. A CE-IVDR-certified transparent AI platform refers to an AI system for in vitro diagnostics that adheres to EU regulatory standards and delivers clear, auditable, and easily understandable decision-making. As an illustration, in May 2025, Diagnostics.ai, a diagnostic testing firm based in the UK, unveiled PCR.AI, an intelligent solution aimed at expediting and enhancing PCR diagnostics. This system automates and accelerates the interpretation of real-time PCR diagnostics with an accuracy exceeding 99.9%. It ensures transparency by explicitly detailing how each result is reached, thus securing regulatory compliance and elevating clinical confidence. This development markedly boosts laboratory efficiency, reduces inaccuracies, and facilitates uninterrupted regulatory adherence for molecular diagnostics.

Which Companies Form The Competitive Landscape Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj

Access The Complete Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

Which Region Contributes The Most To The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company

Artificial Intelligence In The Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Ai In Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Ai In Medical Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market From 2026 To 2030?

The market size for artificial intelligence (ai) in in vitro diagnostics (ivd) has seen considerable expansion in recent times. It is anticipated to expand from $3.04 billion in 2025 to reach $3.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.4%. This market’s past growth can be attributed to several factors including an increased need for accurate diagnostic tools, the development of laboratory infrastructure, the growing occurrence of chronic illnesses, the integration of digital diagnostic instruments, and breakthroughs in biomarker research.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market is anticipated to show significant expansion in the coming years. Its value is projected to reach $7.01 billion by 2030, driven by a compound annual growth rate (CAGR) of 18.1%. This expansion during the forecast period is largely due to factors such as the broadening of cloud-based diagnostic platforms, the incorporation of AI with genomics, advancements in point-of-care AI diagnostics, increased capital in personalized medicine, and a rising requirement for quick and economical testing. Noteworthy trends for the forecast period include AI-enabled laboratory automation, predictive disease diagnostics, data-driven test interpretation, cloud-based diagnostic platforms, and personalized patient profiling.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

Which Key Factors Are Driving The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Growth?

The escalating need for personalized medicine is anticipated to drive the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market moving ahead. Personalized medicine signifies a healthcare approach that tailors prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. This field is expanding due to advancements in genomic data and sequencing technologies, which facilitate more accurate, targeted, and effective treatments customized for each patient. Artificial intelligence (AI) in in vitro diagnostics (IVD) aids personalized medicine by analyzing intricate diagnostic data to pinpoint patient-specific disease patterns, thereby enabling precise, timely, and individualized treatment choices. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, a rise from six in 2022. The newly approved personalized treatments for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Consequently, the growing demand for personalized medicine is propelling the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market.

What Are The Key Segment Divisions In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Segment Structure?

The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning

3) By Deployment Model: Cloud-Based, On-Premise, Hybrid

4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:

1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems

2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices

3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

Which Trends Are Guiding The Direction Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Leading firms within the artificial intelligence (AI) in in vitro diagnostics (IVD) market are prioritizing the creation of sophisticated solutions, including CE-IVDR-certified transparent AI platforms, with the goal of improving diagnostic precision, optimizing operational processes, and aiding individualized patient treatment. Such a platform refers to an AI system designed for in vitro diagnostics, which adheres to EU regulatory criteria and offers decision-making processes that are transparent, verifiable, and easy to comprehend. As an illustration, in May 2025, Diagnostics.ai, a diagnostic testing firm based in the UK, introduced PCR.AI, an intelligent offering intended to speed up and improve PCR diagnostics. This solution automates and quickens the analysis of real-time PCR diagnostics, boasting an accuracy of over 99.9%. It provides transparency by explicitly demonstrating the derivation of each result, thereby guaranteeing regulatory adherence and increasing clinical confidence. Ultimately, this substantially improves laboratory effectiveness, minimizes inaccuracies, and facilitates effortless regulatory conformity for molecular diagnostics.

Which Organizations Are Engaged In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj

Get The Full Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

Which Region Accounts For The Largest Portion Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company

Artificial Intelligence In The Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Ai In Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Ai In Medical Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market At The End Of The 2026–2030 Forecast Period?

The market for artificial intelligence (AI) in in vitro diagnostics (IVD) has seen considerable expansion recently. It is projected to increase from $3.04 billion in 2025 to $3.6 billion in 2026, at a compound annual growth rate (CAGR) of 18.4%. The historical growth of this market can be attributed to factors such as an escalating demand for precise diagnostics, the expansion of laboratory infrastructure, a higher prevalence of chronic diseases, the integration of digital diagnostic instruments, and progress in biomarker research.

The artificial intelligence (ai) in in vitro diagnostics (ivd) market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $7.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. This anticipated growth during the forecast period is primarily driven by factors such as the proliferation of cloud-based diagnostic platforms, the convergence of AI with genomics, advancements in point-of-care AI diagnostics, increased capital allocation towards personalized medicine, and a heightened need for swift and economical testing solutions. Key trends foreseen for this period encompass AI-driven laboratory automation, predictive disease identification, interpretation of tests through data analysis, widespread adoption of cloud-based diagnostic platforms, and individualized patient profiling.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The escalating need for individualized healthcare is anticipated to fuel the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market moving forward. Personalized medicine defines a healthcare methodology that customizes prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. This approach is gaining traction as advancements in genomic data and sequencing technologies enable more precise, targeted, and effective treatments tailored to each patient. Artificial intelligence (AI) in in vitro diagnostics (IVD) contributes to personalized medicine by analyzing complex diagnostic data to identify patient-specific disease patterns, thereby facilitating accurate, timely, and customized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Therefore, the growing demand for personalized medicine is a significant driver of the artificial intelligence (AI) in in vitro diagnostics (IVD) market’s growth.

What Segment Types Make Up The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning

3) By Deployment Model: Cloud-Based, On-Premise, Hybrid

4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:

1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems

2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices

3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

Which Market Trends Are Creating New Opportunities In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are concentrating on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms. These initiatives aim to improve diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform is defined as an AI system for in vitro diagnostics that meets EU regulatory standards and offers clear, auditable, and understandable decision-making. For example, in May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, an intelligent solution crafted to accelerate and enhance PCR diagnostics. This system automates and speeds up the interpretation of real-time PCR diagnostics with over 99.9% accuracy. It ensures transparency by clearly demonstrating how each result is obtained, thereby securing regulatory compliance and boosting clinical trust. This development significantly improves laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.

Who Are The Key Players Driving Competition In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj

Read the full artificial intelligence (ai) in in vitro diagnostics (ivd) market report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

Which Regions Are Projected To Dominate The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In The Coming Years?

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company

Artificial Intelligence In The Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Ai In Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Ai In Medical Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market At The End Of The 2026–2030 Forecast Period?

The market for artificial intelligence (AI) in in vitro diagnostics (IVD) has seen considerable expansion recently. It is projected to increase from $3.04 billion in 2025 to $3.6 billion in 2026, at a compound annual growth rate (CAGR) of 18.4%. The historical growth of this market can be attributed to factors such as an escalating demand for precise diagnostics, the expansion of laboratory infrastructure, a higher prevalence of chronic diseases, the integration of digital diagnostic instruments, and progress in biomarker research.

The artificial intelligence (ai) in in vitro diagnostics (ivd) market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $7.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. This anticipated growth during the forecast period is primarily driven by factors such as the proliferation of cloud-based diagnostic platforms, the convergence of AI with genomics, advancements in point-of-care AI diagnostics, increased capital allocation towards personalized medicine, and a heightened need for swift and economical testing solutions. Key trends foreseen for this period encompass AI-driven laboratory automation, predictive disease identification, interpretation of tests through data analysis, widespread adoption of cloud-based diagnostic platforms, and individualized patient profiling.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The escalating need for individualized healthcare is anticipated to fuel the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market moving forward. Personalized medicine defines a healthcare methodology that customizes prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. This approach is gaining traction as advancements in genomic data and sequencing technologies enable more precise, targeted, and effective treatments tailored to each patient. Artificial intelligence (AI) in in vitro diagnostics (IVD) contributes to personalized medicine by analyzing complex diagnostic data to identify patient-specific disease patterns, thereby facilitating accurate, timely, and customized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Therefore, the growing demand for personalized medicine is a significant driver of the artificial intelligence (AI) in in vitro diagnostics (IVD) market’s growth.

What Segment Types Make Up The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning

3) By Deployment Model: Cloud-Based, On-Premise, Hybrid

4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:

1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems

2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices

3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

Which Market Trends Are Creating New Opportunities In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are concentrating on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms. These initiatives aim to improve diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform is defined as an AI system for in vitro diagnostics that meets EU regulatory standards and offers clear, auditable, and understandable decision-making. For example, in May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, an intelligent solution crafted to accelerate and enhance PCR diagnostics. This system automates and speeds up the interpretation of real-time PCR diagnostics with over 99.9% accuracy. It ensures transparency by clearly demonstrating how each result is obtained, thereby securing regulatory compliance and boosting clinical trust. This development significantly improves laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.

Who Are The Key Players Driving Competition In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj

Read the full artificial intelligence (ai) in in vitro diagnostics (ivd) market report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

Which Regions Are Projected To Dominate The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In The Coming Years?

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company

Artificial Intelligence In The Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Ai In Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Ai In Medical Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market At The End Of The 2026–2030 Forecast Period?

The market for artificial intelligence (AI) in in vitro diagnostics (IVD) has seen considerable expansion recently. It is projected to increase from $3.04 billion in 2025 to $3.6 billion in 2026, at a compound annual growth rate (CAGR) of 18.4%. The historical growth of this market can be attributed to factors such as an escalating demand for precise diagnostics, the expansion of laboratory infrastructure, a higher prevalence of chronic diseases, the integration of digital diagnostic instruments, and progress in biomarker research.

The artificial intelligence (ai) in in vitro diagnostics (ivd) market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $7.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. This anticipated growth during the forecast period is primarily driven by factors such as the proliferation of cloud-based diagnostic platforms, the convergence of AI with genomics, advancements in point-of-care AI diagnostics, increased capital allocation towards personalized medicine, and a heightened need for swift and economical testing solutions. Key trends foreseen for this period encompass AI-driven laboratory automation, predictive disease identification, interpretation of tests through data analysis, widespread adoption of cloud-based diagnostic platforms, and individualized patient profiling.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The escalating need for individualized healthcare is anticipated to fuel the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market moving forward. Personalized medicine defines a healthcare methodology that customizes prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. This approach is gaining traction as advancements in genomic data and sequencing technologies enable more precise, targeted, and effective treatments tailored to each patient. Artificial intelligence (AI) in in vitro diagnostics (IVD) contributes to personalized medicine by analyzing complex diagnostic data to identify patient-specific disease patterns, thereby facilitating accurate, timely, and customized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Therefore, the growing demand for personalized medicine is a significant driver of the artificial intelligence (AI) in in vitro diagnostics (IVD) market’s growth.

What Segment Types Make Up The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning

3) By Deployment Model: Cloud-Based, On-Premise, Hybrid

4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:

1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems

2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices

3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

Which Market Trends Are Creating New Opportunities In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are concentrating on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms. These initiatives aim to improve diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform is defined as an AI system for in vitro diagnostics that meets EU regulatory standards and offers clear, auditable, and understandable decision-making. For example, in May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, an intelligent solution crafted to accelerate and enhance PCR diagnostics. This system automates and speeds up the interpretation of real-time PCR diagnostics with over 99.9% accuracy. It ensures transparency by clearly demonstrating how each result is obtained, thereby securing regulatory compliance and boosting clinical trust. This development significantly improves laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.

Who Are The Key Players Driving Competition In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj

Read the full artificial intelligence (ai) in in vitro diagnostics (ivd) market report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

Which Regions Are Projected To Dominate The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In The Coming Years?

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company

Artificial Intelligence In The Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Ai In Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Ai In Medical Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the digital papanicolaou (pap) smear analyzer market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market covering 2026–2035?

The artificial intelligence (AI) in in vitro diagnostics (IVD) market has experienced substantial expansion in recent years. This market is forecasted to increase from $3.04 billion in 2025 to $3.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.4%. The historical growth can be attributed to various factors, including an elevated demand for precise diagnostics, the development of laboratory infrastructure, a growing prevalence of chronic diseases, the adoption of digital diagnostic tools, and advancements in biomarker research.

The artificial intelligence (ai) in in vitro diagnostics (ivd) market is projected to experience swift expansion over the coming years. This market is set to reach $7.01 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 18.1%. Key factors driving this growth during the forecast period include the proliferation of cloud-based diagnostic platforms, the fusion of AI with genomics, the emergence of point-of-care AI diagnostics, rising investments in personalized medicine, and a heightened need for quick and economical testing solutions. Significant trends anticipated in this period encompass AI-enabled laboratory automation, predictive diagnostics for diseases, data-driven interpretation of tests, cloud-based diagnostic platforms, and individualized patient profiling.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The rising need for personalized medicine is projected to stimulate the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market in the future. Personalized medicine defines a healthcare strategy that tailors prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. This approach is gaining traction as advancements in genomic data and sequencing technologies enable more accurate, targeted, and effective treatments customized for individual patients. Artificial intelligence (AI) in in vitro diagnostics (IVD) supports personalized medicine by analyzing complex diagnostic data to pinpoint patient-specific disease patterns, which facilitates precise, timely, and customized treatment decisions. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. The new personalized treatments approved in 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Therefore, the expanding demand for personalized medicine is fueling the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market.

What Leading Segments Are Studied In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning

3) By Deployment Model: Cloud-Based, On-Premise, Hybrid

4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:

1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems

2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices

3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

Which Trends Are Shaping Activity Within The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating within the artificial intelligence (AI) in in vitro diagnostics (IVD) market are directing their efforts toward developing sophisticated solutions, particularly CE-IVDR-certified transparent AI platforms, to elevate diagnostic accuracy, streamline operational processes, and support individualized patient care. A CE-IVDR-certified transparent AI platform signifies an AI system utilized for in vitro diagnostics that adheres to EU regulatory standards and delivers clear, auditable, and comprehensible decision-making. As an example, in May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, a smart solution designed to accelerate and enhance PCR diagnostics. This tool automates and speeds up the interpretation of real-time PCR diagnostics with over 99.9% accuracy. It offers transparency by explicitly demonstrating how each result is generated, ensuring regulatory compliance and strengthening clinical trust. This significantly improves laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.

Which Key Players Are Driving Competition In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

Which Region Is Projected To Lead The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market During The Forecast Period?

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company

Artificial Intelligence In The Diagnostic Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Ai In Cancer Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Ai In Medical Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Current (2025) And Forecast (2029) Sizes Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The artificial intelligence (AI) in in vitro diagnostics (IVD) market size has seen rapid expansion in recent years. It is forecast to increase from $2.57 billion in 2024 to $3.04 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 18.5%. This historical growth can be attributed to several factors, including an escalating shortage of skilled healthcare professionals and radiologists, increasing governmental and regulatory support for artificial intelligence-based diagnostics, the expanding application of artificial intelligence in genomic and molecular diagnostics, growing awareness among clinicians about the accuracy offered by artificial intelligence-enabled diagnostics, and the rising availability of cloud-based artificial intelligence diagnostic solutions.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market is anticipated to expand significantly in the upcoming years. It is projected to reach $5.94 billion by 2029, growing at a compound annual growth rate (CAGR) of 18.2%. This growth over the forecast period is driven by factors such as a greater need for quick and accurate diagnostic results, an increasing occurrence of chronic and infectious diseases, a rising demand for personalized and precision medicine methods, an enhanced focus on early disease detection and prevention, and the growing digitalization of healthcare along with the adoption of electronic health records (EHR). Key trends expected during this period include advancements in deep learning for pathology and imaging, innovations in fully automated high-throughput analyzers, the integration of natural language processing into diagnostic reporting, progress in AI-enabled remote diagnostic platforms, and the incorporation of AI with wearable and point-of-care devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

Which Drivers Are Shaping The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Industry’s Market Share?

The escalating demand for personalized medicine is projected to drive the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market moving ahead. Personalized medicine refers to a healthcare strategy that tailors prevention, diagnosis, and treatment according to an individual’s genetic profile, lifestyle, and environment. Its increasing adoption is propelled by advancements in genomic data and sequencing technologies, which enable more accurate, targeted, and effective treatments specifically designed for individual patients. Artificial intelligence (AI) in in vitro diagnostics (IVD) aids personalized medicine by scrutinizing complex diagnostic data to identify patient-specific disease patterns, thereby allowing for precise, timely, and customized treatment decisions. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also included seven cancer drugs and three for other diseases and conditions. Consequently, the rising demand for personalized medicine is powering the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market.

What Are The Different Segment Classifications Within The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The artificial intelligence (AI) in in vitro diagnostics (IVD) market covered in this report is segmented as

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning

3) By Deployment Model: Cloud-Based, On-Premise, Hybrid

4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:

1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems

2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices

3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

Which Market Trends Are Creating New Opportunities In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Industry?

Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are concentrating their efforts on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms, to enhance diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform refers to an AI system for in vitro diagnostics that fulfills EU regulatory standards and offers clear, auditable, and understandable decision-making. For instance, in May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, an intelligent solution engineered to accelerate and enhance PCR diagnostics. This tool automates and speeds up the interpretation of real-time PCR diagnostics with over 99.9% accuracy. It provides transparency by clearly demonstrating how each result is generated, thereby ensuring regulatory compliance and boosting clinical trust. This significantly improves laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.

Which Major Firms Are Strengthening Their Position In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Industry?

Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, and Aiforia Technologies Oyj.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

How Is Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Demand Varying Across Different Regions?

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) in in vitro diagnostics (IVD) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2025, By The Business Research Company

Ai In Medical Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report

Artificial Intelligence In The Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Ai In Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Current (2025) And Forecast (2029) Sizes Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The artificial intelligence (AI) in in vitro diagnostics (IVD) market size has seen rapid expansion in recent years. It is forecast to increase from $2.57 billion in 2024 to $3.04 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 18.5%. This historical growth can be attributed to several factors, including an escalating shortage of skilled healthcare professionals and radiologists, increasing governmental and regulatory support for artificial intelligence-based diagnostics, the expanding application of artificial intelligence in genomic and molecular diagnostics, growing awareness among clinicians about the accuracy offered by artificial intelligence-enabled diagnostics, and the rising availability of cloud-based artificial intelligence diagnostic solutions.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market is anticipated to expand significantly in the upcoming years. It is projected to reach $5.94 billion by 2029, growing at a compound annual growth rate (CAGR) of 18.2%. This growth over the forecast period is driven by factors such as a greater need for quick and accurate diagnostic results, an increasing occurrence of chronic and infectious diseases, a rising demand for personalized and precision medicine methods, an enhanced focus on early disease detection and prevention, and the growing digitalization of healthcare along with the adoption of electronic health records (EHR). Key trends expected during this period include advancements in deep learning for pathology and imaging, innovations in fully automated high-throughput analyzers, the integration of natural language processing into diagnostic reporting, progress in AI-enabled remote diagnostic platforms, and the incorporation of AI with wearable and point-of-care devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

Which Drivers Are Shaping The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Industry’s Market Share?

The escalating demand for personalized medicine is projected to drive the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market moving ahead. Personalized medicine refers to a healthcare strategy that tailors prevention, diagnosis, and treatment according to an individual’s genetic profile, lifestyle, and environment. Its increasing adoption is propelled by advancements in genomic data and sequencing technologies, which enable more accurate, targeted, and effective treatments specifically designed for individual patients. Artificial intelligence (AI) in in vitro diagnostics (IVD) aids personalized medicine by scrutinizing complex diagnostic data to identify patient-specific disease patterns, thereby allowing for precise, timely, and customized treatment decisions. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also included seven cancer drugs and three for other diseases and conditions. Consequently, the rising demand for personalized medicine is powering the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market.

What Are The Different Segment Classifications Within The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

The artificial intelligence (AI) in in vitro diagnostics (IVD) market covered in this report is segmented as

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning

3) By Deployment Model: Cloud-Based, On-Premise, Hybrid

4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:

1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems

2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices

3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

Which Market Trends Are Creating New Opportunities In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Industry?

Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are concentrating their efforts on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms, to enhance diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform refers to an AI system for in vitro diagnostics that fulfills EU regulatory standards and offers clear, auditable, and understandable decision-making. For instance, in May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, an intelligent solution engineered to accelerate and enhance PCR diagnostics. This tool automates and speeds up the interpretation of real-time PCR diagnostics with over 99.9% accuracy. It provides transparency by clearly demonstrating how each result is generated, thereby ensuring regulatory compliance and boosting clinical trust. This significantly improves laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.

Which Major Firms Are Strengthening Their Position In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Industry?

Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, and Aiforia Technologies Oyj.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

How Is Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Demand Varying Across Different Regions?

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) in in vitro diagnostics (IVD) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2025, By The Business Research Company

Ai In Medical Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report

Artificial Intelligence In The Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Ai In Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model